DNC Biotechnology
D&C Biotechnology is a leading company in the global in vitro diagnostic device market, specializing in next-generation urine diagnostic solutions and digital healthcare. Their mission is to improve medical environments and protect family health through innovative ideas and technology, including their award-winning products like URINE CHECK-IT and URINE CHECK-ER, which have received multiple recognitions such as CES Innovation Awards and Good Design awards. The company actively collaborates with international partners and research institutions to develop localized medical devices and advance healthcare technology worldwide.
Industries
Nr. of Employees
small (1-50)
DNC Biotechnology
Products
URINE CHECK-IT
Clinical-grade urine chemistry analyzer integrating an optical biosensing detection path to provide simplified, hygienic, point-of-care urine testing for medical institutions. Domestic medical device certification and a device manufacturing license are documented on the company's site.
URINE CHECK-ER
Home-use urine diagnostic device designed for simple in-home sample analysis with companion app connectivity to enable result viewing and linkage to remote consultation services.
Cup-type urine test consumable
Single-use cup consumable with multi-zone reagent pads for semi-quantitative colorimetric assessment of standard urine analytes, intended for use with analyzers or visual comparison.
Mobile health application and data platform
Mobile application and cloud platform for aggregating diagnostic results, storing longitudinal data, providing basic analytics, and enabling connections between users and healthcare providers.
URINE CHECK-UP
Next-generation AI urine diagnostic solution featuring an all-in-one cup type urine test kit for precise measurement of 10 parameters.
U-CHECK
AI-integrated Digital Health Platform and companion app for urine diagnostics, providing multi-health care integration with urine analyzers and lifestyle devices.
URINE CHECK-IT
Clinical-grade urine chemistry analyzer integrating an optical biosensing detection path to provide simplified, hygienic, point-of-care urine testing for medical institutions. Domestic medical device certification and a device manufacturing license are documented on the company's site.
URINE CHECK-ER
Home-use urine diagnostic device designed for simple in-home sample analysis with companion app connectivity to enable result viewing and linkage to remote consultation services.
Cup-type urine test consumable
Single-use cup consumable with multi-zone reagent pads for semi-quantitative colorimetric assessment of standard urine analytes, intended for use with analyzers or visual comparison.
Mobile health application and data platform
Mobile application and cloud platform for aggregating diagnostic results, storing longitudinal data, providing basic analytics, and enabling connections between users and healthcare providers.
URINE CHECK-UP
Next-generation AI urine diagnostic solution featuring an all-in-one cup type urine test kit for precise measurement of 10 parameters.
U-CHECK
AI-integrated Digital Health Platform and companion app for urine diagnostics, providing multi-health care integration with urine analyzers and lifestyle devices.
Services
Joint research agreements and field trials to localize and validate POCT urine diagnostic devices in clinical settings with academic and hospital partners.
Integration and deployment of result-management software and device interfaces into hospital workflows to enable real-time result viewing and operational reporting.
Provision of a mobile app and cloud platform for users to receive test results, aggregate device and lifelog data, and connect with healthcare providers for remote consultation.
Joint research agreements and field trials to localize and validate POCT urine diagnostic devices in clinical settings with academic and hospital partners.
Integration and deployment of result-management software and device interfaces into hospital workflows to enable real-time result viewing and operational reporting.
Provision of a mobile app and cloud platform for users to receive test results, aggregate device and lifelog data, and connect with healthcare providers for remote consultation.
Expertise Areas
- Point-of-care testing (POCT) systems
- Urine chemistry assay development
- Optical biosensor research
- Digital health and telemedicine platforms
Key Technologies
- Flexible optical biosensors
- One-step urine analysis workflow
- Multi-zone colorimetric reagent pads
- Cup-type consumable test kits
News & Updates
D&C Biotechnology was selected as a final candidate in the Biohealth Medical Device and Digital Healthcare category of the ‘2025 Super-Gap Startup Nurturing Project (DIPS 1000+)’ organized by the Ministry of SMEs and Startups, receiving funding and policy support.
URINE CHECK-ER received the CES 2025 Innovation Award, recognizing its technological innovation in home healthcare urine analysis.
D&C Biotechnology was selected as a final candidate in the Biohealth Medical Device and Digital Healthcare category of the ‘2025 Super-Gap Startup Nurturing Project (DIPS 1000+)’ organized by the Ministry of SMEs and Startups, receiving funding and policy support.
URINE CHECK-ER received the CES 2025 Innovation Award, recognizing its technological innovation in home healthcare urine analysis.